Hi Step, Yes this board is dead since Knox and me cut our discussion. You're right that we believed pship agreement that's why we didn't sell out in August 2017 when PPS was close to $1 ($6 after R/S). I'm afraid it was a clever trick of Soon to attache all MS payment some Aldox result. (i.e. filing the NDA) or manufacturing and commercialisig Aldox as a drug. He had another (secret) plan: to use Aldox in all NANT trials without paying a single $! He bought shares - at a higyher price level . that's all. It's a very easy and cheap way to get Aldox rights. I don't know SK was involved, but I think yes! I hope once PSS will be that position when Aldox NDA could open some possibilty to step ahead, and he'll do it. Then CYTR could earn some MS and pps will jump up! Maybe when Abraxane right Will expire or some trials need to support by a real phase3 drug! I didn't think that investing here could last so long! Waiting game! GLTY
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.